25 July 2018
Posting of Annual Report and Notice of AGM
Collagen Solutions plc (AIM: COS), the developer and manufacturer of biomaterials and regenerative medicines for the enhancement and extension of human life, confirms that the Annual Report and Accounts for the year ended 31 March 2018 ('2018 Annual Report and Accounts'), the Notice of Annual General Meeting ('AGM') and a Form of Proxy will be posted to shareholders on 26 July 2018. A copy of the 2018 Annual Report and Accounts will be available to download from the Company website from that date.
The AGM will be held at 11.00am on 22 August 2018 at 3 Robroyston Oval, Nova Business Park, Glasgow G33 1AP.
For additional information on Collagen Solutions, please visit: www.collagensolutions.com
|Collagen Solutions Plc
Jamal Rushdy, CEO
Hilary Spence, CFO
|Lisa Baderoon, Head of Investor Relations||Tel: +44 (0) 7721 413 496 or firstname.lastname@example.org|
|Cenkos Securities plc (Nominated Adviser and Broker)
Steve Cox (Corporate Finance)
|Tel: 0207 397 8900|
|Walbrook PR Ltd||Tel: 020 7933 8780 or email@example.com|
|Anna Dunphy||Mob: 07876 741 001|
|Helen Cresswell||Mob: 07841 917 679|
About Collagen Solutions:
Collagen Solutions Plc is a global supplier, developer, and manufacturer of medical grade collagen, tissues, and related medical devices and components for use in regenerative medicine, medical devices and in-vitro diagnostics and research. The Company is also expanding its range of biomaterials-based finished medical devices based on its internal and acquired intellectual property for commercialisation with partners via licensing and distribution arrangements, including ChondroMimetic®. The Company's products are used in a wide variety of applications including orthopaedics, cardiovascular, dental, plastic surgery, wound healing, neurology and urology.
For more information go to: www.collagensolutions.com.